James T. Fuller

2.6k total citations
26 papers, 1.5k citations indexed

About

James T. Fuller is a scholar working on Immunology, Epidemiology and Virology. According to data from OpenAlex, James T. Fuller has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 15 papers in Epidemiology and 11 papers in Virology. Recurrent topics in James T. Fuller's work include Immunotherapy and Immune Responses (12 papers), HIV Research and Treatment (11 papers) and Immune Cell Function and Interaction (8 papers). James T. Fuller is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), HIV Research and Treatment (11 papers) and Immune Cell Function and Interaction (8 papers). James T. Fuller collaborates with scholars based in United States, Cyprus and Canada. James T. Fuller's co-authors include Deborah H. Fuller, Georg Widera, Joel R. Haynes, Mary S. Wu, William F. Swain, Tim Shipley, Russell M. Dixon, Rupert Vessey, Michael J. Roy and J Culp and has published in prestigious journals such as PLoS ONE, Journal of Virology and Annals of the New York Academy of Sciences.

In The Last Decade

James T. Fuller

26 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James T. Fuller United States 17 893 487 472 457 446 26 1.5k
Ludwig Deml Germany 23 765 0.9× 431 0.9× 488 1.0× 523 1.1× 268 0.6× 53 1.5k
Linda S. Klavinskis United Kingdom 27 1.5k 1.7× 580 1.2× 627 1.3× 499 1.1× 500 1.1× 56 2.4k
Mark L. Bagarazzi United States 20 1.3k 1.5× 585 1.2× 621 1.3× 687 1.5× 428 1.0× 38 2.0k
Michael A. Egan United States 25 850 1.0× 559 1.1× 883 1.9× 510 1.1× 608 1.4× 41 1.8k
Erika Hammarlund United States 16 944 1.1× 755 1.6× 877 1.9× 738 1.6× 369 0.8× 24 2.0k
Claude Méric France 21 452 0.5× 668 1.4× 561 1.2× 514 1.1× 582 1.3× 24 1.7k
Mary-Ellen Davies United States 16 772 0.9× 589 1.2× 540 1.1× 430 0.9× 314 0.7× 21 1.4k
Ismar R. Haga United Kingdom 16 915 1.0× 637 1.3× 484 1.0× 358 0.8× 234 0.5× 19 1.5k
Drew Hannaman United States 25 726 0.8× 390 0.8× 184 0.4× 479 1.0× 554 1.2× 55 1.6k
Meredith Hunter United States 13 852 1.0× 417 0.9× 1.0k 2.2× 297 0.6× 433 1.0× 21 1.6k

Countries citing papers authored by James T. Fuller

Since Specialization
Citations

This map shows the geographic impact of James T. Fuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James T. Fuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James T. Fuller more than expected).

Fields of papers citing papers by James T. Fuller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James T. Fuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James T. Fuller. The network helps show where James T. Fuller may publish in the future.

Co-authorship network of co-authors of James T. Fuller

This figure shows the co-authorship network connecting the top 25 collaborators of James T. Fuller. A scholar is included among the top collaborators of James T. Fuller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James T. Fuller. James T. Fuller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lippy, Adriana, Brian G. Oliver, James T. Fuller, et al.. (2021). Rapid progression is associated with lymphoid follicle dysfunction in SIV-infected infant rhesus macaques. PLoS Pathogens. 17(5). e1009575–e1009575. 5 indexed citations
2.
O’Connor, Megan A., Sandra Dross, Debbie Bratt, et al.. (2021). Effects of therapeutic vaccination on the control of SIV in rhesus macaques with variable responsiveness to antiretroviral drugs. PLoS ONE. 16(6). e0253265–e0253265. 9 indexed citations
3.
Forero, Adriana, Debbie Bratt, James T. Fuller, et al.. (2017). Multigenic DNA vaccine induces protective cross-reactive T cell responses against heterologous influenza virus in nonhuman primates. PLoS ONE. 12(12). e0189780–e0189780. 23 indexed citations
4.
Stone, Brad, Arnold Kas, Zachary P. Billman, et al.. (2016). Complex Minigene Library Vaccination for Discovery of Pre-Erythrocytic Plasmodium T Cell Antigens. PLoS ONE. 11(4). e0153449–e0153449. 7 indexed citations
5.
Rosinski, Steven Lawrence, Brad Stone, Scott S. Graves, et al.. (2015). Development of a Minor Histocompatibility Antigen Vaccine Regimen in the Canine Model of Hematopoietic Cell Transplantation. Transplantation. 99(10). 2083–2094. 6 indexed citations
6.
Cui, Xinle, Goutam Sen, Gouri Chattopadhyay, et al.. (2013). A novel tetrameric gp3501–470 as a potential Epstein–Barr virus vaccine. Vaccine. 31(30). 3039–3045. 48 indexed citations
7.
Yager, Eric J., et al.. (2012). Optimizing Particle-Mediated Epidermal Delivery of an Influenza DNA Vaccine in Ferrets. Humana Press eBooks. 940. 223–237. 11 indexed citations
8.
Vojnov, Lara, Alexander T. Bean, Eric Peterson, et al.. (2011). DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4+ T cells, but few subdominant epitope-specific CD8+ T cells. Vaccine. 29(43). 7483–7490. 6 indexed citations
9.
Loudon, Peter T., Eric J. Yager, Amithi Narendran, et al.. (2010). GM-CSF Increases Mucosal and Systemic Immunogenicity of an H1N1 Influenza DNA Vaccine Administered into the Epidermis of Non-Human Primates. PLoS ONE. 5(6). e11021–e11021. 60 indexed citations
10.
11.
Fuller, Deborah H., Tim Shipley, Todd M. Allen, et al.. (2007). Immunogenicity of hybrid DNA vaccines expressing hepatitis B core particles carrying human and simian immunodeficiency virus epitopes in mice and rhesus macaques. Virology. 364(2). 245–255. 14 indexed citations
12.
Fuller, Deborah H., Premeela A. Rajakumar, Mary S. Wu, et al.. (2006). DNA immunization in combination with effective antiretroviral drug therapy controls viral rebound and prevents simian AIDS after treatment is discontinued. Virology. 348(1). 200–215. 30 indexed citations
13.
Vogel, Thorsten U., Matthew R. Reynolds, Deborah H. Fuller, et al.. (2003). Multispecific Vaccine-Induced Mucosal Cytotoxic TLymphocytes Reduce Acute-Phase Viral Replication but Fail inLong-Term Control of Simian Immunodeficiency VirusSIVmac239. Journal of Virology. 77(24). 13348–13360. 86 indexed citations
14.
Fuller, Deborah H., Premeela A. Rajakumar, Lawrence Wilson, et al.. (2002). Induction of Mucosal Protection against Primary, Heterologous Simian Immunodeficiency Virus by a DNA Vaccine. Journal of Virology. 76(7). 3309–3317. 98 indexed citations
15.
16.
McCluskie, Michael J., Cynthia L. Brazolot Millan, Robert Gramzinski, et al.. (1999). Route and Method of Delivery of DNA Vaccine Influence Immune Responses in Mice and Non-Human Primates. Molecular Medicine. 5(5). 287–300. 149 indexed citations
17.
Rodrı́guez, Fernando, Ling An, Stephanie Harkins, et al.. (1998). DNA Immunization with Minigenes: Low Frequency of Memory Cytotoxic T Lymphocytes and Inefficient Antiviral Protection Are Rectified by Ubiquitination. Journal of Virology. 72(6). 5174–5181. 119 indexed citations
18.
Schmaljohn, Connie S., L. VanderZanden, M Bray, et al.. (1997). Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge. Journal of Virology. 71(12). 9563–9569. 106 indexed citations
19.
Haynes, Joel R., Dennis E. McCabe, William F. Swain, Georg Widera, & James T. Fuller. (1996). Particle-mediated nucleic acid immunization. Journal of Biotechnology. 44(1-3). 37–42. 60 indexed citations
20.
Fuller, James T., Deborah H. Fuller, Dennis E. McCabe, Joel R. Haynes, & Georg Widera. (1995). Immune Responses to Hepatitis B Virus Surface and Core Antigens in Mice, Monkeys, and Pigs after Accell® Particle‐Mediated DNA Immunization. Annals of the New York Academy of Sciences. 772(1). 282–284. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ludwig Deml Breakdown of academic impact, for papers by Linda S. Klavinskis Breakdown of academic impact, for papers by Mark L. Bagarazzi Breakdown of academic impact, for papers by Michael A. Egan Breakdown of academic impact, for papers by Erika Hammarlund Breakdown of academic impact, for papers by Claude Méric Breakdown of academic impact, for papers by Mary-Ellen Davies Breakdown of academic impact, for papers by Ismar R. Haga Breakdown of academic impact, for papers by Drew Hannaman Breakdown of academic impact, for papers by Meredith Hunter
Rankless by CCL
2026